Updated:
Upcoming AbbVie dividendAbbVie has remained silent on the possibility of paying dividends during 2026.
The dividend from AbbVie, 1.73 dollars, was credited on November 16, 2026, following the ex-dividend on October 15, 2026.
As almost all North American companies do, AbbVie divides the annual dividend payment into four parts, depositing it quarterly in February, May, August and November.
However, its payout is approximately 80% and the dividend yield is around 4%.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio AbbVie Dividends
- Payout Ratio192.94%
- Retained Earnings0.00%
An appropriate payout ratio may vary depending on the industry, the company's growth stage and its financial health.
Dividend calendar of AbbVie
There is no Dividend Calendar of AbbVie defined for 2026.
For a company to have growing dividends by our standards, the annual dividend amount must have increased steadily for at least the last 5 years.
The company's dividend yield is compared to the industry average to determine its positioning.
Imagine you have a list of dividend yields for different companies in an industry. If you look for the "top 25% percentile", you will find a number. This number tells you that the top 25% of the companies with the highest dividends have a yield higher than that number. On the other hand, the "top 75% percentile" shows you another number, which tells you that 75% of the companies have a higher yield than that number, thus showing a more common and less high yield.
For a company to have stable dividends by our standards, it is vital that it has not had an annual decline of more than 10% over the previous year.
Dividend history of AbbVie
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2026 |
10/15/2026 07/15/2026 04/15/2026 01/16/2026 |
1.73 $ 1.73 $ 1.73 $ 1.73 $ |
6.92 $ |
| 2025 |
10/15/2025 07/15/2025 04/15/2025 01/15/2025 |
1.64 $ 1.64 $ 1.64 $ 1.64 $ |
6.56 $ |
| 2024 |
10/15/2024 07/15/2024 04/12/2024 01/12/2024 |
1.55 $ 1.55 $ 1.55 $ 1.55 $ |
6.2 $ |
| 2023 |
10/12/2023 07/13/2023 04/13/2023 01/12/2023 |
1.48 $ 1.48 $ 1.48 $ 1.48 $ |
5.92 $ |
| 2022 |
10/13/2022 07/14/2022 04/13/2022 01/13/2022 |
1.41 $ 1.41 $ 1.41 $ 1.41 $ |
5.64 $ |
| 2021 |
10/14/2021 07/14/2021 04/14/2021 01/14/2021 |
1.3 $ 1.3 $ 1.3 $ 1.3 $ |
5.2 $ |
| 2020 |
10/14/2020 07/14/2020 04/14/2020 01/14/2020 |
1.18 $ 1.18 $ 1.18 $ 1.18 $ |
4.72 $ |
| 2019 |
10/11/2019 07/12/2019 04/12/2019 01/14/2019 |
1.07 $ 1.07 $ 1.07 $ 1.07 $ |
4.28 $ |
| 2018 |
10/12/2018 07/12/2018 04/12/2018 01/11/2018 |
0.96 $ 0.96 $ 0.96 $ 0.71 $ |
3.59 $ |
| 2017 |
10/12/2017 07/12/2017 04/11/2017 01/11/2017 |
0.64 $ 0.64 $ 0.64 $ 0.64 $ |
2.56 $ |
| 2016 |
10/12/2016 07/13/2016 04/13/2016 01/13/2016 |
0.57 $ 0.57 $ 0.57 $ 0.57 $ |
2.28 $ |
| 2015 |
10/13/2015 07/13/2015 04/13/2015 01/13/2015 |
0.51 $ 0.51 $ 0.51 $ 0.49 $ |
2.02 $ |
| 2014 |
10/10/2014 07/11/2014 04/11/2014 01/13/2014 |
0.42 $ 0.42 $ 0.42 $ 0.4 $ |
1.66 $ |
| 2013 |
10/10/2013 07/11/2013 04/11/2013 01/11/2013 |
0.4 $ 0.4 $ 0.4 $ 0.4 $ |
1.6 $ |
Information about AbbVie
AbbVie is a company involved in the pharmaceutical industry, designing, manufacturing and marketing drugs and solutions for the treatment of a wide variety of diseases.
It was founded from the fragmentation of Abbot Laboratories in 2013, establishing its headquarters in Illinois, USA, has sales in more than 175 countries, with subsidiaries in Germany, Bermuda and The Bahamas.
Its products cover the treatment of more than 60 pathologies, including immunology, oncology, neuroscience, ophthalmology, esthetics and virology, with research and development operations in 20 countries and more than 50,000 employees distributed among its various factories.
Its operations emphasize research and personalization of therapies, tailored to the needs of each patient, investing in technologies such as precision medicine, genetics, data convergence and genomics.
Frequently asked questions about AbbVie dividends
AbbVie pays dividends on a Quarterly basis.
AbbVie is listed on the New York Stock Exchange and is part of the Nyse Composite.
AbbVie has the Ticker or stock code ABBV.
The CEO of AbbVie in 2026 is Mr. Robert A. Michael CPA.
The ISIN of AbbVie is US00287Y1091.
AbbVie has a growing dividend program. In the last 5 years, dividends have been at least equal to or higher than the previous year.
Check the latest comments and participate in the live chat on AbbVie stocks (ABBV).
No comments yet. Be the first to join in.